ArticleTranslational andrology and urology2025
Tracking and analysis of testicular cancer burden in adolescents and young adults globally in Asia and in China: 1990-2021 epidemiological trends.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Testicular cancer (TC) is the most common malignancy among males aged 15-44 years and is rising in incidence, particularly in Asia and China. Despite improved survival rates, TC imposes a heavy economic and psychological burden. This study aims to analyze the trends in TC incidence, mortality, and the burden of disease across different regions and sociodemographic indices, and to forecast future trends. Methods: Data from the Global Burden of Disease (GBD) study were used to analyze the age-standardized incidence rate (ASIR), age-standardized prevalence rate, mortality, and disability-adjusted life years. Joinpoint regression, decomposition analysis, and Nordpred models were used to assess the trends and forecasts. Results: In 2021, the global ASIR for TC in adolescents and young adults was 0.37 per 100,000, with 5,698 deaths and a decrease in the age-standardized death rates (annual percentage change in the age-specific death rate: -0.28). The incidence and prevalence increased in regions with a medium sociodemographic index (SDI) but decreased in regions with a high SDI. East Asia and Southeast Asia showed notable increases in incidence and prevalence, although mortality decreased. Conclusions: Epidemiological changes and population growth have contributed to the global increase in TC incidence, while advances in early diagnosis and treatment have reduced mortality. Projections suggest a continued rise in TC burden, particularly in China, emphasizing the need for enhanced prevention, early screening, and international collaboration in TC research and healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.